TATA MEMORIAL HOSPITAL KHARGHAR
Sector 22, Utsav Chowk - CISF Rd, Owe Camp, Kharghar, Navi Mumbai, Maharashtra 410210
Contact number:
(022) 2740 5000/ 6873 5000
+91-22-2740 5085
Email- [email protected]

A 930-bed cancer treatment centre of the Tata Memorial Hospital (TMH)
at Kharghar near Mumbai, an official said here Wednesday. The TMH, located in Parel in central Mumbai, has a
capacity of 700 beds, while the Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) at Kharghar in Navi Mumbai will have 930 beds, the hospital official said.

The Kharghar centre will also have a 300-room accommodation facility for patients' relatives, he said.
The TMH research centre at Kharghar was set up 16 years ago, which is now being upgraded to the treatment centre as well to ease the burden on the Parel hospital which was set up in 1941.

The TMH at Parel treats 60,000 new patients every year and conducts around 10,000 major and minor surgeries. The treatment of paediatric cancer will shift to Kharghar, the hospital official said. Paediatric cancer patients who come from across the country face inconvenience at the Parel hospital because there is no facility for staying, he said.

The Tata Memorial Hospital was set up in 1941 by the Sir Dorabji Tata Trust. It was then an 80-bed facility with an annual budget of Rs five lakh. Today it is one of Asia's biggest centres for cancer treatment with 700 beds and an annual budget of about Rs 300 crore.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the state of art of R&D wing of the Tata Memorial Centre. It is located in the picturesque settings at the foot hills of the Sahyadri mountains in Kharghar, Navi Mumbai.  ACTREC comprises of, the Cancer Research Institute (CRI), Clinical Research Centre (CRC) and Centre for Cancer Epidemiology (CEC), a setting that is unique in India and built and evolved with a vision to provide comprehensive cancer care to one and all, through its motto of excellence in services, education and research.

The three centers have specific agendas, focus and unique capabilities. They work independently and in collaboration towards a common goal i.e., to advance research on all aspects of cancer, improve diagnosis, predict prognosis and treatment

CRI: Scientists in CRI undertake multi-pronged investigations into cancer biology, which address basic and translational research queries using human tumors, experimental animals and cells in culture, with an aim to provide the tools for chemoprevention, early diagnosis, prognosis and therapy. Commensurate with these goals the research projects at CRI encompass the following thematic – Biomolecular Structure, Function and alteration; Cell and Tumor Biology; Carcinogenesis, Genome Biology and Precision Medicine; Therapy Resistance and Stem Cell Biology; Tumor Immunology and Immunotherapy; Cancer Theranostics and Clinical Pharmacology. 

CRC: CRC and Hospital are integral, vital constituents of ACTREC that are making considerable headway into clinical research while focusing on advanced modes of cancer therapy. In keeping with the overall mandate of the ACTREC, the CRC is focusing initially on pediatric cancers, brain tumours, head and neck cancer, cervical cancer, breast cancer, cancer genetics and technology evaluation.

CCE: The Centre for Cancer Epidemiology is commissioned with a focus to assess and evaluate the cancer burden in the country.   
Funding: The clinicians, clinician scientists and basic scientists of the Centre are engaged in a large number of clinical trials and audits, as well as institutional, intramural and extramural projects. The trials involve collaborations between the Centre and industry particularly the Pharma sector. Funding support for most projects come from either the Centre itself or from governmental funding agencies such as DST, DBT, ICMR, etc. While some of the studies are stand alone, the vast majorities are collaborative projects involving close interaction between scientists and/or clinicians within and outside the Centre; some are multicentric international projects

Education: ACTREC continues its emphasis and focus on its academic programs, prime amongst which is the Doctoral program.  The Ph.D. programs under Life Sciences and Health Sciences are affiliated to the Homi Bhabha National Institute – a deemed university recognized by the University Grants Commission. 

CRC has an important mandate of development of a structured post-doctoral educational programme in every clinical discipline of oncology. This includes Medical and Paediatric Oncology, Cancer Genetics, Bone Marrow and Stem Cell Transplant, Neuro-Oncology, Radiation Biology, High Precision Radiotherapy, Brachytherapy, Paediatric Surgical Oncology, and Clinical Research Methodology. The Homi Bhabha National Institute (a deemed university) is a first step in that direction, which would enable the education programme to take root successfully.